MAGELLAN LONGEVITY
HomeResearchStudy library › Therapeutic potential of beetroot juice in peripheral artery disease…
Study summary · Cardiovascular & vascular aging

What are the potential therapeutic effects of beetroot juice (BRJ) in the management of peripheral artery disease (PAD)?

In one paragraph

Beetroot / Dietary Nitrate, a review (Nitric Oxide 2025, PMID 40139306) — the review indicates that beetroot juice can improve exercise performance, lower blood pressure, improve endothelial function, enhance skeletal muscle microvascular function, and improve central autonomic nervous system function. No numeric effect size is reported for Beetroot / Dietary Nitrate in the source abstract.

Source: Nitric Oxide 2025, PMID 40139306 ↗ · Research map · How Magellan grades evidence · evidence confidence: low

Nitric Oxide · 2025 · PMID 40139306 · DOI 10.1016/j.niox.2025.03.003

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Beetroot juice may improve several markers of cardiovascular health and exercise performance relevant to peripheral artery disease.

The question

What are the potential therapeutic effects of beetroot juice (BRJ) in the management of peripheral artery disease (PAD)?

What they tested

Beetroot juice, rich in nitrate and betaine, may offer therapeutic benefits for PAD by increasing nitric oxide (NO) bioavailability through the nitrate-nitrite-NO pathway, thereby improving blood flow and other physiological functions.

How they did it

This is a review article that explores the potential therapeutic effects of beetroot juice in PAD management by examining existing evidence related to its bioactive compounds and their mechanisms of action, particularly the nitrate-nitrite-NO pathway.

What they found

The review indicates that beetroot juice can improve exercise performance, lower blood pressure, improve endothelial function, enhance skeletal muscle microvascular function, and improve central autonomic nervous system function.

What it means

Beetroot and its rich bioactive compounds show promise as a novel supportive therapy for improving peripheral artery disease.

Limitations

The abstract does not explicitly state any limitations of the review itself, but rather focuses on the potential benefits of beetroot juice.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“Beetroot nitrate is metabolized via the nitrate–nitrite–nitric oxide pathway, increasing NO bioavailability; NO is a vasodilator that improves blood flow, lowers blood pressure and improves endothelial function.”— from the published abstract, Nitric Oxide 2025

The paper at a glance

TitleTherapeutic potential of beetroot juice in peripheral artery disease (review of the nitrate–nitrite–NO pathway)
JournalNitric Oxide
Year2025
PMID40139306 ↗
DOI10.1016/j.niox.2025.03.003 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Beetroot / Dietary Nitrate

Meta-analyses of randomized trials show that beetroot juice and dietary nitrate lower blood pressure—about 5 mmHg systolic on average across trials in hypertension, and in one pivotal placebo-controlled trial in hypertensive patients roughly 7-8 mmHg, including 24-hour ambulatory readings, sustained over four weeks…

Beetroot / Dietary Nitrate

Beetroot (Beta vulgaris) is a root vegetable that is one of the richest dietary sources of inorganic…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What are the potential therapeutic effects of beetroot juice (BRJ) in the management of peripheral artery disease (PAD)? [Plain-English summary of Nitric Oxide 2025, PMID 40139306, DOI 10.1016/j.niox.2025.03.003]. Magellan Longevity. https://magellanlongevity.com/study/beet_no.html
BibTeX
@misc{magellan_beet_no, title = {What are the potential therapeutic effects of beetroot juice (BRJ) in the management of peripheral artery disease (PAD)?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/beet_no.html}}, note = {Plain-English summary of PubMed PMID 40139306; DOI 10.1016/j.niox.2025.03.003; Nitric Oxide 2025. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/beet_no.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 40139306 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.